Clinical and Pathological Analysis of 4910 Patients Who Received Renal Biopsies at a Single Center in Northeast China

Table 2

Pathological types of SGN during different periods.

Pathological types	2008-12		2013-17		2008-17		P value
	N	(%)	N	(%)	N	(%)
Systemic Diseases	348	(58.6)	266	(46.6)	614	(52.7)	<0.001
LN	209	(35.2)	187	(32.7)	396	(34.0)	0.380
HSPN	135	(22.7)	74	(13.0)	209	(17.9)	<0.001
SSARD	4	(0.7)	3	(0.5)	7	(0.6)	1.000
MCTARD	0	(0)	2	(0.4)	2	(0.2)	0.240
Vascular diseases	86	(14.5)	145	(25.4)	231	(19.8)	<0.001
HTARD	38	(6.4)	63	(11.0)	101	(8.7)	0.005
MHTARD	26	(4.4)	26	(4.5)	52	(4.4)	0.884
SVARD	14	(2.3)	54	(9.5)	68	(5.8)	<0.001
IN	7	(1.2)	2	(0.4)	9	(0.8)	0.201
HUS	1	(0.2)	0	(0)	1	(0.1)	1.000
Metabolic diseases	94	(15.8)	128	(22.4)	222	(19.1)	0.004
DN	53	(8.9)	83	(14.5)	136	(11.7)	0.003
AN	26	(4.4)	27	(4.7)	53	(4.5)	0.774
LCDD	2	(0.3)	8	(1.4)	10	(0.9)	0.099
C3GN	0	(0)	2	(0.4)	2	(0.2)	0.240
LPN	0	(0)	1	(0.2)	1	(0.1)	0.490
CUAN	1	(0.2)	0	(0)	1	(0.1)	1.000
OAG	8	(1.3)	4	(0.7)	12	(1.0)	0.423
ING	4	(0.7)	3	(0.5)	7	(0.6)	1.000
Infectious diseases	66	(11.1)	32	(5.6)	98	(8.4)	0.001
HBV-GN	65	(10.9)	31	(5.4)	96	(8.2)	0.001
HCV-GN	1	(0.2)	1	(0.2)	2	(0.2)	1.000
Total	594	(100)	571	(100)	1165	(100)	-

Abbreviations: LN, lupus nephritis; HSPN, Henoch-Schönlein purpura nephritis; SSARD, Sjogren's syndrome associated renal damage; MCTARD, Mixed connective tissue disease associated renal damage; HT/MHTARD, hypertension/malignant hypertension-associated renal damage; SVARD, systemic vasculitis-associated renal damage; IN, ischemic nephropathy; HUS, hemolysis aemolytic uraemic syndrome; DN, diabetic nephropathy; AN, amyloidosis nephropathy; LCDD, light chain deposition nephropathy; C3GN, C3 glomerulopathy; LPN, lipoprotein glomerulopathy; CUAN, chronic uric acid nephropathy; OAG, obesity-associated glomerulopathy; ING, idiopathic nodular glomerulosclerosis; HBV-GN, hepatitis B virus associated nephritis; HCV-GN, hepatitis C virus associated nephritis.